Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients

Intensive Care Medicine

Volumn 30, Issue 4, 2004, Pages 633-638

  Carrasco, M N ^a   Bueno, A ^a   De Las Cuevas, C ^a   Jimenez, S ^a   Salinas, I ^a   Sartorius, A ^a   Recio, T ^a   Generelo, M ^a   Ruiz Ocana F ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Antiseptic catheter; Catheter colonization; Catheter related blood infection; Central venous catheter; Heparin catheter; Intensive care unit

Indexed keywords

CHLORHEXIDINE; HEPARIN; SULFADIAZINE SILVER;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BLOOD CULTURE; BLOOD FLOW; CANDIDA; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; EVALUATION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL BED; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICROORGANISM; PATIENT; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

ADULT; AGED; ANTI-INFECTIVE AGENTS, LOCAL; ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; SILVER SULFADIAZINE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 1942532709     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-2093-4     Document Type: Article

References (41)

1. Raad II, Bodey GP (1992) Infection complications of indwelling vascular catheters. Clin Infect Dis 15:197-208
2. Pittet D, Tamara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra cost and attributable mortality. JAMA 271:1598-1601
3. Elliott TSJ (1997) Catheter-associated infections: new developments in prevention. In: Buchard H (ed) Current topics in intensive care. Saunders, London, pp 182-205
4. Vincent JL, Bihari DJ, Suter PM et al. (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 274:639-644
5. National Nosocomial Infections Surveillance (NNIS) System Report (2001) Data summary from January 1992-June 2001. Am J Infect Control 29:404-421
6. Bjornson H, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE (1982) Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 92:720-727
7. Bach A, Eberhardt H, Frick A, Schmidt H, Böttiger B, Martin E (1999) Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med 27:515-521
8. Elliott TS, Most HA, Tebbs SE, Wilson IC, Bonser RS, Graham TR, Burker LP, Faroqui MH (1997) Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 16:210-213
9. Raad II, Baba M, Bodey GP (1995) Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 20:593-597
10. Raad I (1993) Intravascular catheter-related infections. Lancet 351:893-898
11. Linares J, Sitges-Serra A, Garau J, Perez L, Martin R (1985) Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 21:357-360
12. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP (1993) Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168:400-406
13. Maki DG, Mermel LA (1998) Infections due to infusion therapy. In: Bennett JS, Brachman PS (eds) Hopital infections. Lippincott-Raven, Philadelphia, pp 689-724
14. Henderson DK (2000) Infections due to percuataneous intravascular devices. In: Mandel GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennetts principles and practice of infectious diseases. Churchill Livingstone, New York, pp 3005-3015
15. Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O (1996) Surface heparinization of central catheters reduce microbial colonization in vitro and in vivo. Results from a prospective, randomized trial. Crit Care Med 24:1482-1489
16. Mermel LA, Stolz SM, Maki DG (1993) Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis 167:920-924
17. Darouiche RO, Raad II (1997) Prevention of catheter-related infection: the skin. Nutrition 13 [Suppl 4]:26-29S
18. Modak SM, Sampath L (1992) Development and evaluation of a new polyurethane central venous antisepstic catheter. Complications Surg 11:23-29
19. Pemberton Beaty L, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E (1996) No difference in catheter sepsis between standard and antiseptic central venous catheters. Arch Surg 131:986-989
20. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ (1996) Failure of antiseptic bonding to prevent central venous catheter-related infection and central sepsis. Am Surg 62:641-646
21. Logghe C, Van Ossel C, Dhoore W, Ezzedine H, Wauters G, Haxhe JJ (1997) Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukemic patients: a randomized controlled trial. J Hosp Infect 37:145-156
22. Loo S, Heerden PV van, Gollege CL, Roberts BL, Power BM (1997) Infection in central lines: antiseptic-impregnated catheter vs standard non-impregnated catheters. Anaesth Intensive Care 25:637-639
23. Heard SO, Wagle M, Vijayakumar E et al. (1998) Influence of triple lumen central venous catheter coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 158:81-87
24. Hanley EM, Veeder A, Smith T, Drusano G, Currie E, Venezia RA (2000) Evaluation of an antiseptic triple-lumen catheter in an intensive care unit. Crit Care Med 28:366-370
25. Maki DG, Stolz SM, Wheeler S, Mermel LA (1997) Prevention of central venous catheter-related bloodstream infection by use of an antiseptic- impregnated catheter. A randomized, controlled trial. Ann Intern Med 127:257-266
26. Hannan M, Juste RN, Umasanker S, Glendenning A, Nightingale C, Azadian B, Soni N (1999) Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia 54:868-872
27. Collin RG (1999) Decreasing catheter colonization through the use of antiseptic-impregnated catheter. Chest 115:1632-1640
28. Sheng W-H, Ko W-J, Wang J-T, Chang S-C, Hsueh P-R, Luh K-T (2000) Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care patients. Diagn Microbiol Infect Dis 38:1-5
29. Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous catheter-related infections. N Engl J Med 296:1305-1309
30. Brun-Bruisson C, Abrouk F, Legrand P, Huet S, Rapin M (1987) Diagnosis of central venous catheters-related sepsis: critical level of quantitative tip cultures. Arch Intern Med 147:873-877
31. Carrasco MN, Nogueira R, Cobo N, De Miguel E, Garcia N, De Las Cuevas C, Ruiz-Ocaña F (1998) Central venous catheters. Evaluating the clinical suspicion of infection. Abstract K-20. ICAAC, San Diego
32. Sitges-Serra A, Liñares J (1988) Limitations of semiquantitative method for catheter culture. J Clin Microbiol 26:1074-1075
33. Yorganci K, Krepel C, Weigelt JA, Edmiston CE (2002) In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. Eur J Clin Microbiol Infect Dis 21:379-384
34. Yorganci K, Krepel C, Weigelt JA, Edmiston CE (2002) Activity of anti-bacterial impregnated central venous catheter against Klebsiella pneumoniae. Intensive Care Med 28:438-442
35. Schmitt SK, Knapp C, Hall GS, Longworth DL, McMahon JT, Washington JA (1996) Impact of chlorhexidine-silver sulfadiazine impregnated central venous catheters on in vitro quantitation of catheter associated bacteria. J Clin Microbiol 34:508-511
36. Sheretz RJ, Ely EW, Westbrook DM et al. (2000) Education of physicians-intraining can decrease the risk for vascular catheter infection. Ann Intern Med 132:641-648
37. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D (2000) Impact of prevention strategy targeted at vascular-access care on incidence of infection acquired in intensive care. Lancet 355:1864-1868
38. Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM (1995). Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr 126:50-54
39. Pierce CM, Wade A, Mock Q (2000) Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 26:967-972
40. Eiff C von, Proctor RA, Peters G (2001) Coagulase-negative staphylococci pathogens have a major role in nosocomial infections. Post Grad Med 110:4
41. Mermel LA (2001) New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis 7:197-199